Healthcare CMO Market to 2027- Global Analysis & Outlook by Service and Geography – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare
CMO Market to 2027- Global Analysis and Forecasts by Service; and
Geography” report has been added to ResearchAndMarkets.com’s
offering.

The global healthcare CMO market is expected to reach US$ 223,355.6 Mn
in 2027 from US$ 80,479.4 in 2018. The healthcare CMO market is
estimated to grow with a CAGR of 12.2% from 2019-2027.

The market is driven by the factors such as, increasing inclination of
pharmaceutical and medical device manufacturers towards outsourcing,
increasing patent cliffs and rising geriatric population coupled with
the increasing production of drugs & medical devices. However, the
challenge such as lack of skilled professionals for CMO likely to impact
the growth of the market in the forecast period.

Increasing patent cliffs are likely to grow market dynamically. The
rising numbers of the contract manufacturing across the globe are
entering in the production of the generic drugs as the legislation
encouraged competition to benefit consumers. The CMOs help in the
manufacturing the drug with the bioequivalence testing and the drugs are
produced with the current good manufacturing practices. The CMO allows
to reduce the cost of manufacturing and enhance the production in bulk
quantities.

Additionally as per the paper’s statistics it is stated that
approximately US$ 194 billion in the innovative drugs sales are at risk
during the 2017-2020. Also an estimate of nearly US$ 31 billion could be
lost due to the expiry of patents alone in 2018. Therefore, owing to the
above mentioned factors the market for the healthcare CMO is likely to
propel during the forecast period.

Global healthcare CMO market, based on service was segmented into major
segments such as pharmaceutical contract manufacturing services and
medical device contract manufacturing services. The pharmaceutical
contract manufacturing services segment is expected to dominate the
market in 2027, owing to the advantages provided by the contract
manufacturing organizations and he rising prevalence of chronic and
acute disease across the world. In addition, the segment is also
anticipated to witness the fastest growth rate during the forecast
period, 2018 to 2027.

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

1.3.1 Global Healthcare CMO Market – by Service

1.3.2 Global Healthcare CMO Market – by Geography

2. Global Healthcare CMO Market – Key Takeaways

3. Research Methodology

3.1.1 Coverage

3.1.2 Secondary Research

3.1.3 Primary Research

4. Global Healthcare CMO – Market Landscape

4.1 Overview

4.2 Pest Analysis

4.2.1 North America – Pest Analysis

4.2.2 Europe – Pest Analysis

4.2.3 Asia Pacific – Pest Analysis

4.2.4 Middle East & South Africa – Pest Analysis

4.2.5 South and Central America – Pest Analysis

5. Global Healthcare CMO Market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Inclination of Pharmaceutical and Medical Device
Manufacturers Towards Outsourcing

5.1.2 Increasing Patent Cliffs

5.1.3 Rising Geriatric Population Coupled With the Increasing Production
of Drugs & Medical Devices

5.2 Key Market Challenges

5.2.1 Lack of Skilled Professionals For CMO

5.3 Key Market Opportunities

5.3.1 Rising Demand In Developing Regions

5.3.2 Growth Opportunities Due To Biosimilars Market

5.4 Market Trend

5.4.1 Rise In Market Consolidation

5.5 Impact Analysis

6. Healthcare CMO Market – Global Analysis

6.1 Global Healthcare CMO Market Revenue Forecasts and Analysis

6.2 Global Healthcare CMO Market, by Geography – Forecasts and Analysis

6.3 Performance of Key Players

6.3.1 Catalent Inc.

6.3.2 Lonza

6.3.3 Integer Holdings Corporation

6.3.4 Flex Ltd.

6.4 Expert Opinions

7. Global Healthcare CMO Market Analysis – by Service

7.1 Overview

7.2 Global Healthcare CMO Market by Service, 2018 & 2027 (%)

7.3 Pharmaceutical Contract Manufacturing Services Market

7.3.1 Overview

7.3.2 Global Pharmaceutical Contract Manufacturing Services Market
Revenue and Forecasts To 2027 (US$ Mn)

7.3.3 Active Pharmaceutical Ingredients (API) Market

7.3.3.1 Overview

7.3.3.2 Global Active Pharmaceutical Ingredients (API) Market Revenue
and Forecasts To 2027 (US$ Mn)

7.3.4 Final Dosage Form Manufacturing Market

7.3.4.1 Overview

7.3.4.2 Global Final Dosage Form Manufacturing Market Revenue and
Forecasts To 2027 (US$ Mn)

7.3.5 Packaging Market

7.3.5.1 Overview

7.3.5.2 Global Packaging Market Revenue and Forecasts To 2027 (US$ Mn)

7.4 Medical Device Contract Manufacturing Services Market

7.4.1 Overview

7.4.2 Global Medical Device Contract Manufacturing Market Revenue and
Forecasts To 2027 (US$ Mn)

7.4.3 Outsourcing Design Market

7.4.3.1 Overview

7.4.3.2 Global Outsourcing Design Market Revenue and Forecasts To 2027
(US$ Mn)

7.4.4 Device Manufacturing Market

7.4.4.1 Overview

7.4.4.2 Global Device Manufacturing Market Revenue and Forecasts To 2027
(US$ Mn)

7.4.5 Final Goods Assembly Market

7.4.5.1 Overview

7.4.5.2 Global Final Goods Assembly Market Revenue and Forecasts To 2027
(US$ Mn)

8. Healthcare CMO Market Revenue and Forecasts To 2027 – Geographical
Analysis

8.1 North America Healthcare CMO Market

8.2 Europe Healthcare CMO Market

8.3 Asia Pacific Healthcare CMO Market

8.4 Middle East & Africa Healthcare CMO Market

8.5 South and Central America Healthcare CMO Market

9. Healthcare CMO Market -Industry Landscape

9.1 Overview

9.2 Growth Strategies In the Healthcare CMO Market, 2015-2018

9.3 Organic Developments

9.4 Organic Growth Strategies In the Healthcare CMO Market, 2016-2018

9.5 Expansion

9.6 Service Launch

9.7 Others

9.8 Inorganic Developments

9.9 Inorganic Growth Strategies In the Healthcare CMO Market, 2015-2018

9.10 Agreement

9.11 Acquisition

9.12 Partnerships

9.13 Collaboration

10. Healthcare CMO Market – Key Company Profiles

10.1 Royal DSM

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Financial Overview

10.1.4 Service Portfolio

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Catalent Inc.

10.3 Boehringer Ingelheim International GmbH

10.4 Recipharm AB (Publ)

10.5 Fareva

10.6 Lonza

10.7 Piramal Enterprises Ltd.

10.8 Dr. Reddy’s Laboratories Ltd.

10.9 Almac Group

10.10 Famar Health Care Services

For more information about this report visit https://www.researchandmarkets.com/r/jzqu7f

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services, Pharmaceutical
Manufacturing